http://www.londonstockexchange.com/exchange/news/market-news/market-news-detail.html?announcementId=10811399if you guys havent read this already.however this is from the ggg board and the azx board has a different story.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%